Level C· Early human research exploring benefitsProspective StudyPubMed

Decellularized human amniotic membrane: how viable is it as a delivery system for human adipose tissue-derived stromal cells?

Gholipourmalekabadi M., Sameni M., Radenkovic D., Mozafari M., Mossahebi-Mohammadi M., Seifalian A.

Prospective Study on Burns, published in Cell Prolif (2016) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Cell Prolif (2016)
Country
England
Reported sample size
—
Source database
PubMed
PMID
26840647
PMCID
PMC6496672
DOI
10.1111/cpr.12240
Citations
63

Abstract (original English)

Objectives Human amniotic membrane (HAM) has been widely used in soft tissue engineering both in its fresh form and decellularized; its efficiency to aid treatment of burn injuries is well known. On the other hand, it has been reported clinically by several studies that human adipose-derived stem cells (hADSC) are a promising cell source for cell therapy for burns. Recently, we have reported a new technique for decellularization of HAM. In this study, potential of prepared decellularized HAM (dHAM) as a viable support for proliferation and delivery of hADSC was investigated. Materials and methods Amniotic membranes were collected, decellularized and preserved according to the protocol described in our previously published study. hADSC were obtained from the patients undergoing elective liposuction surgery and cells were then seeded on the decellularized membrane for various times. Efficiency of the decellularized membrane as a delivery system for hADSC was investigated by MTT, LDH specific activity, DAPI staining and SEM. Results The results showed that dHAM provided a supporting microenvironment for cell growth without producing any cytotoxic effects. In addition, the cells were spread out and actively attached to the dHAM scaffold. Conclusion These results strongly suggest that dHAMs have considerable potential as 3D cell-carrier scaffolds for delivery of hADSC, in tissue eng

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAmnionCell DeathCell SurvivalCells, CulturedHumansIndolesStaining and LabelingStromal CellsTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research